Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
- Camacho-Toledano, C.
- Machín-Díaz, I.
- Calahorra, L.
- Cabañas-Cotillas, M.
- Otaegui, D.
- Castillo-Triviño, T.
- Villar, L.M.
- Costa-Frossard, L.
- Comabella, M.
- Midaglia, L.
- García-Domínguez, J.M.
- García-Arocha, J.
- Ortega, M.C.
- Clemente, D.
Journal:
Journal of Neuroinflammation
ISSN: 1742-2094
Year of publication: 2022
Volume: 19
Issue: 1
Type: Article